SFG
XBI icon

SNS Financial Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SNS Financial Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-24,078
Closed -$1.04M – 146
2013
Q3 		$1.04M Buy
+24,078
New +$975K 0.66% 33

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SNS Financial Group's XBI Position: Q4 2013 in Review

SNS Financial Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2013, closing a stake of 24,078 shares — an estimated $1.04M sold.

SNS Financial Group first reported a position in XBI in Q3 2013 and held it in 1 quarter. The position peaked at $1.04M in Q3 2013. 122 funds tracked by Wall St. Rank hold XBI as of Q4 2013.

  • SNS Financial Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2013 after selling out during the quarter.
  • SNS Financial Group sold 24,078 State Street SPDR S&P Biotech ETF shares in Q4 2013, an estimated $1.04M.
  • SNS Financial Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2013 and held it in 1 quarter.
  • SNS Financial Group's State Street SPDR S&P Biotech ETF position peaked at $1.04M in Q3 2013.
  • 122 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2013.

Based on SNS Financial Group's 13F filing for Q4 2013, filed 14 Feb 2014.